SARS-CoV-2 infection and the antiviral innate immune response

J Mol Cell Biol. 2020 Nov 26;12(12):963-967. doi: 10.1093/jmcb/mjaa071.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antiviral Agents / therapeutic use
  • COVID-19 / immunology*
  • COVID-19 / virology
  • COVID-19 Drug Treatment
  • Genome, Viral
  • Host Microbial Interactions / immunology
  • Humans
  • Immunity, Innate*
  • Interferon Type I / immunology
  • Interferon Type I / therapeutic use
  • Models, Immunological
  • Pandemics
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / immunology*
  • Signal Transduction
  • Viral Proteins / genetics

Substances

  • Antiviral Agents
  • Interferon Type I
  • Viral Proteins